SCHEMBL25926702

SCHEMBL25926702

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4oc5cccc(-c6cccc7oc8ccc(-n9c%10ccccc%10c%10ccccc%109)cc8c67)c5c4c3)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.35
ATM Q13315 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
PLA2G2A P14555 3/20 0.34
PLA2G4A P47712 3/20 0.34
PLA2G10 O15496 1/20 0.34
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
TSHR P16473 2/20 0.33
CHEK2 O96017 1/20 0.33
MAPT P10636 2/20 0.33
TP53 P04637 1/20 0.33
NFKB1 P19838 1/20 0.33
MAPK1 P28482 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
TERT O14746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25926693 0.96 CHEK2 (0.34) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL25926663 0.96 CHEK2 (0.34) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL25926699 0.95 PTGER4 (0.35) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL25926831 0.95 PLA2G2A (0.35) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL26745309 0.95 CHEK2 (0.35) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL23058546 0.95 PLA2G2A (0.33) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL25926570 0.95 PTGER4 (0.33) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL25954224 0.95 BACE1 (0.33) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL24149027 0.94 KDM4E (0.34) KDM4EATML3MBTL1PLA2G2APLA2G4A
SCHEMBL25926890 0.94 KDM4E (0.34) KDM4EATML3MBTL1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-08-03 US disclosed
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE CRY1, PPOX, ORC3 KDM4E 2352/4885ATM 2148/4885L3MBTL1 1454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.